FUND II

Generating profitable returns for investors through medical device innovation
BioStar II
$36M

 

With a final closing in June 2010, BioStar II has has invested in medical device companies specifically focused in the growing markets of cardiology, vascular, and orthopaedics. BioStar II has also invested in one international venture fund, co-founded by one of BioStar’s Medical Venture Partners (MVPs). BioStar II manages committed capital of $36M and is no longer making new investments.

 

Active

 

 

Exits